Americord | WebDisclosure

Switch to English

10651	Sociétés
226542	Mots-clés
155028	Articles
119935	Communiqués

Accueil
Sociétés
Americord

BRÈVE

publiée le 23/02/2024 à 16:30, il y a 2 années 4 mois

Americord réalise une avancée dans le traitement de la maladie du motoneurone grâce aux cellules souches du sang de cordon

Americord Cellules Souches Sang De Cordon Maladie Du Motoneurone Traitement
BRÈVE

publiée le 23/02/2024 à 16:30, il y a 2 années 4 mois

Americord makes breakthrough in treating Motor Neuron Disease with cord blood stem cells

Americord Stem Cells Cord Blood Motor Neuron Disease Treatment
COMMUNIQUÉ DE PRESSE

publié le 23/02/2024 à 16:30, il y a 2 années 4 mois

Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease
Americord releases cord blood stem cells for the treatment of motor neuron disease in India, highlighting the therapeutic potential of stem cells in healthcare

Healthcare Americord Motor Neuron Disease Treatment Cord Blood Stem Cells
COMMUNIQUÉ DE PRESSE

publié le 06/12/2023 à 15:00, il y a 2 années 6 mois

Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey
Americord, a leader in the biobanking industry, has relocated its laboratory from New York City to a state-of-the-art facility in Somerset, New Jersey, marking a milestone in advancing research, product quality, and growth opportunities

Americord Biobanking Laboratory Relocation Research Somerset New Jersey

Les Echos

Publié le 26/06/2026 à 17:45, il y a 12 heures 43 minutes

Combined General Meeting, June 25, 2026
Publié le 26/06/2026 à 17:45, il y a 12 heures 43 minutes

Assemblée générale mixte du 25 juin 2026
Publié le 26/06/2026 à 17:45, il y a 12 heures 43 minutes

Descriptif du programme de rachat d'actions
Publié le 26/06/2026 à 14:44, il y a 15 heures 44 minutes

Safran information
Publié le 26/06/2026 à 14:44, il y a 15 heures 44 minutes

Information Safran

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 27/06/2026 à 01:40, il y a 4 heures 48 minutes

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 6 heures 28 minutes

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 7 heures 28 minutes

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 7 heures 38 minutes

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 8 heures 13 minutes

Revive Therapeutics Announces Proposed Private Placement

Voir tout ACCESSWIRE

EQS Group

Publié le 27/06/2026 à 00:05, il y a 6 heures 23 minutes

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 6 heures 24 minutes

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 6 heures 52 minutes

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 6 heures 52 minutes

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 7 heures

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE